Communiqués PolyPeptide Group AG London S.E.

Actions

0AAJ

CH1110760852

Temps réel estimé Cboe Europe Autres places de cotation 10:30:33 26/06/2024			Varia. 5j.	Varia. 1 janv.
29,92 ^CHF	-4,24%		+6,47%	+78,37%

13/05	Donaldson Company, Inc. et PolyPeptide Group AG s'associent pour améliorer la durabilité de la fabrication des peptides grâce à la technologie de récupération des solvants	CI
19/03	Polypeptide annonce le départ de l'administratrice Dorothee Deuring	AW

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

PolyPeptide : and Donaldson collaborate to develop solvent recovery system for peptide purification	13/05	PU
Hamlet BioPharma secures large scale Alpha1 peptide production in an agreement with Polypeptide Group	18/04	AQ
PolyPeptide announces results of the annual General Meeting 2024	10/04	EQ
PolyPeptide publishes invitation to the annual General Meeting 2024	19/03	EQ
PolyPeptide : publishes invitation to the annual General Meeting 2024	19/03	PU
PolyPeptide with record revenue growth of 43% in H2 2023 versus H1 2023; operational improvements yielding increased profitability and cash flow	12/03	EQ
PolyPeptide signs scientific collaboration agreement	31/10/23	EQ
PolyPeptide secures revolving credit facility	02/10/23	EQ
Transformational progress taking shape, profitability impacted by rapid expansion – appointment of Marc Augustin as new CFO	15/08/23	EQ
PolyPeptide delivers revenue of around EUR 132 million for H1 – expects net loss for H1 and full year 2023	13/07/23	EQ
Hamlet Pharma secures long-term Alpha1 peptide production in an agreement with Polypeptide Group	12/06/23	AQ
PolyPeptide and Numaferm announce partnership to leverage their expertise for the more sustainable production of peptide-based APIs	09/05/23	EQ
PolyPeptide : launches new “Innovation Lab”	08/05/23	PU
PolyPeptide announces results of the annual General Meeting 2023	12/04/23	EQ
PolyPeptide appoints Juan-Jose Gonzalez as CEO and announces change of CFO	04/04/23	AQ
PolyPeptide appoints Juan-José Gonzalez as CEO and announces change of CFO	03/04/23	EQ
PolyPeptide publishes invitation to the annual General Meeting 2023	22/03/23	EQ
PolyPeptide reports weaker performance in 2022 - expects growth to recover in the second half of 2023	14/03/23	AQ
PolyPeptide reports weaker performance in 2022 – expects growth to recover in the second half of 2023	14/03/23	EQ
PolyPeptide: CEO of PolyPeptide resigns	30/01/23	EQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués PolyPeptide Group AG London S.E.

Actions

0AAJ

CH1110760852

Communiqués

Filtres